MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2010 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ CAPITAL |
Anteile |
34.4 M |
Marktkapitalisierung |
$ 521 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.62 | 1.37 % | $ 774 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.86 | -4.62 % | $ 2.44 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 67.5 | 4.9 % | $ 1.82 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 31.72 | -0.97 % | $ 2.81 B | Nasdaq Global Select Market | USA |
 |
Protalix BioTherapeutics
PLX
|
$ 2.86 | 11.28 % | $ 225 M | NYSE American |  Israel |
 |
Lantern Pharma
LTRN
|
$ 0.47 | -22.86 % | $ 5.12 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 1.89 | -7.35 % | $ 119 M | Nasdaq Global Market | USA |
 |
Ocugen
OCGN
|
$ 0.95 | -2.45 % | $ 297 M | Nasdaq Capital Market | USA |
 |
Oncolytics Biotech
ONCY
|
$ 0.38 | -5.64 % | $ 36.4 M | Nasdaq Global Select Market |  Canada |
 |
Minerva Neurosciences
NERV
|
$ 2.47 | -6.08 % | $ 20.9 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 8.09 | 4.93 % | $ 466 M | Nasdaq Global Select Market | Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 169.08 | 0.13 % | $ 16.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 32.8 | 2.4 % | $ 1.57 T | Nasdaq Global Select Market |  France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.3 | 1.66 % | $ 239 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 7.86 | -2.31 % | $ 1.13 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.84 | 0.82 % | $ 668 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.01 | -7.51 % | $ 9.49 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 15.89 | -1.58 % | $ 1.38 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.36 | -14.78 % | $ 101 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.42 | 3.42 % | $ 153 M | Nasdaq Global Select Market | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 136.18 | 0.2 % | $ 8.66 B | Nasdaq Global Select Market | USA |
|
Nuvation Bio
NUVB
|
$ 4.22 | -3.1 % | $ 1.44 B | NYSE | USA |
 |
Novo Nordisk A/S
NVO
|
$ 40.6 | -1.88 % | $ 180 B | NYSE |  Danmark |
 |
Marker Therapeutics
MRKR
|
$ 0.95 | -3.87 % | $ 14.5 M | Nasdaq Global Market | USA |
 |
NextCure
NXTC
|
$ 5.97 | -4.78 % | $ 17 M | Nasdaq Global Select Market | USA |
 |
Rocket Pharmaceuticals
RCKT
|
$ 2.46 | -2.96 % | $ 273 M | Nasdaq Global Select Market | USA |
 |
PMV Pharmaceuticals
PMVP
|
$ 1.22 | -2.8 % | $ 64.1 M | Nasdaq Global Select Market | USA |
 |
Olema Pharmaceuticals
OLMA
|
$ 7.29 | -1.02 % | $ 634 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 136.45 | -1.74 % | $ 11.5 B | Nasdaq Global Market | USA |
 |
Oragenics
OGEN
|
$ 0.35 | -1.47 % | $ 755 K | NYSE American | USA |
 |
Ovid Therapeutics
OVID
|
$ 2.8 | -1.75 % | $ 365 M | Nasdaq Global Select Market | USA |
 |
Passage Bio
PASG
|
$ 3.81 | 11.08 % | $ 12.2 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 66.44 | -1.61 % | $ 9.04 B | Nasdaq Global Select Market | USA |
 |
Relay Therapeutics
RLAY
|
$ 19.81 | -2.87 % | $ 3.4 B | Nasdaq Global Market | USA |
 |
Precigen
PGEN
|
$ 4.51 | -4.76 % | $ 1.41 B | Nasdaq Global Select Market | USA |
 |
Avidity Biosciences
RNA
|
$ 8.23 | -1.79 % | $ 1.13 B | Nasdaq Global Select Market | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.82 | -2.07 % | $ 4.91 M | Nasdaq Capital Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 337.69 | 1.42 % | $ 7.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.78 | 0.53 % | $ 291 M | Nasdaq Global Select Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.31 | -5.07 % | $ 138 M | Nasdaq Global Market |  Niderland |
 |
Ocular Therapeutix
OCUL
|
$ 6.62 | -3.36 % | $ 1.24 B | Nasdaq Global Select Market | USA |
 |
PolyPid Ltd.
PYPD
|
$ 6.3 | 0.96 % | $ 103 M | Nasdaq Global Select Market | Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.46 | -0.84 % | $ 16 M | Nasdaq Global Select Market | USA |
 |
uniQure N.V.
QURE
|
$ 22.7 | -0.39 % | $ 1.31 B | Nasdaq Global Select Market | Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 16.13 | -1.71 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.11 | 2.45 % | $ 57 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.66 | -5.08 % | $ 395 M | Nasdaq Global Select Market,SPB | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 43.83 | 4.22 % | $ 788 M | Nasdaq Global Select Market | USA |
 |
SELLAS Life Sciences Group
SLS
|
$ 8.38 | -2.39 % | $ 914 M | Nasdaq Capital Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |